Aim Bulletin
Angus Energy strikes gas construction deal with National Grid
Angus Energy updated the market on progress made on its interests at Saltfleetby on Thursday, reporting that its wholly-owned subsidiary Angus Energy Weald Basin No. 3 has entered into a gas construction agreement with National Grid.
Allergy Therapeutics pleased with invalidation of B301 trial data
Biotechnology company Allergy Therapeutics announced the outcome of scientific advice from the German Regulatory Authority, the Paul Ehrlich Institute (PEI), over invalidation of the primary endpoint data of the Birch MATA MPL pivotal phase 3 clinical trial, or ‘B301’, on Thursday.
Advanced Medical Solutions expects Covid impact to tail off through second half
Advanced Medical Solutions Group updated the market on its trading on Thursday, reporting “significant progress” in a number of areas, despite the adverse impact of Covid-19.
DX joins Covid-19 testing logistics consortium
Logistics provider DX announced on Thursday that its DX Express division has joined a consortium of UK parcel delivery providers, to manage the nationwide collection and delivery of Covid-19 home-testing kits.
Belvoir to take over the Nottingham's estate agent services
Estate agent franchise Belvoir Group has entered into a strategic alliance with the Nottingham Building Society, it announced on Thursday.
Science in Sport H1 revenues drop less than expected
Sports nutrition business Science in Sport posted a softer than expected drop in revenues during the first half of 2020, driven by a shift to online sales and strong growth in the US.
Telit Communications H1 profits grow despite Covid-19
Internet of Things enabler Telit Communications expects first-half profits to have grown in the six months ended 30 June despite "some slowing" in customer demand as a result of the Covid-19 pandemic.
Deltex Medical impacted by Covid-19 in 'a number of ways'
Output monitoring systems provider Deltex Medical warned on Thursday that trading had been affected in "a number of ways" as a result of the Covid-19 pandemic.
IMImobile Q1 profits rise following 3Cinteractive acquisition
Cloud software group IMImobile posted improved first-quarter profits on Thursday with its recent acquisition of 3Cinteractive boosted overall trading.
Tracsis warns of revenue drop, trades 'better than expected'
Traffic and transportation technology group Tracsis said on Thursday that overall trading during the Covid-19 pandemic had been "better than originally expected" but still cautioned of a roughly 18% hit to revenues as a result of the coronavirus.
Ceres Power records 'significant' FY growth
Fuel cell technology group Ceres Power said on Thursday that it had recorded "significant growth" across all areas of the business in the twelve months ended 30 June.
Escape Hunt to reopen England venues on Saturday
Escape Hunt announced on Thursday that all eight of its venues in England will reopen on 11 July, following their closure on 24 March as a result of Covid-19 restrictions.
VR Education signs licence agreement with Japan education firm
Virtual reality (VR) technology company VR Education has signed a multi-year enterprise licence agreement with Tokyo Global Gateway (TGG) for use of its proprietary ‘Engage’ platform, effective 1 September, it announced on Thursday.
Salt Lake Potash on track with procurement at Lake Way
Salt Lake Potash updated the market on procurement at the Lake Way Project on Thursday, with all major long-lead items for the process plant and non-process infrastructure tracking in line with, or ahead of, the project schedule.
Great Western Mining upbeat on results from Olympic Gold Project
Great Western Mining updated the market on its recently-acquired option over the Olympic Gold Project in Nevada on Thursday, reporting that among the four potential targets so far identified, a preliminary assessment has been completed on the OMCO Mine Extension prospect, confirming the potential of the claim area.
Mercia to cash in on sale of the Native Antigen Company
Regionally-focussed Mercia Asset Management announced the sale of the Native Antigen Company (NAC) on Thursday, to life sciences tools company LGC, for total cash of up to £18m.